News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Bard1 Life Sciences.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
10 at 10: These ASX stocks are imprinted at the top this morning
Experts
Scopo’s Health Powerplays: Show me the (grant) money
Health & Biotech
Three investors toss an ‘unsolicited’ $3m at Race Oncology
Health & Biotech
Check up: Pot, takeovers, and COVID-19 are making investors happy
News
Lunchtime ASX Small Cap Wrap: Who wants to hear the good news today?
Health & Biotech
Bard1 makes Sienna an offer it can’t refuse: a $45m merger
Health & Biotech
Cancer Wars Part 2: These are the ASX small cap diagnostics plays that want to conquer cancer
Health & Biotech
Biotech: Medlab lands another clinical trial for its cannabis mouth spray
News
Lunchtime ASX small cap wrap: Who’s got a hundred questions today?
Health & Biotech
Dr Irmgard Irminger-Finger’s team is now into cancer vaccines – and one shows good signs in mice
Health & Biotech
8 biotechs that either flew or sunk on clinical trial results in 2018
Health & Biotech
Two-thirds of early cancer detector Bard1’s entitlement offer has gone begging
News
Lunchtime ASX small cap wrap: stocks lift as market recovers
Health & Biotech
Trying to pick the next Biotron or BARD1? Here’s what you need to know
Health & Biotech